Antibody 10-1074 suppresses viremia in HIV-1-infected individuals

被引:386
作者
Caskey, Marina [1 ]
Schoofs, Till [1 ]
Gruell, Henning [2 ,3 ,4 ]
Settler, Allison [1 ]
Karagounis, Theodora [1 ]
Kreider, Edward F. [5 ,6 ]
Murrell, Ben [7 ]
Pfeifer, Nico [8 ]
Nogueira, Lilian [1 ]
Oliveira, Thiago Y. [1 ]
Learn, Gerald H. [5 ,6 ]
Cohen, Yehuda Z. [1 ]
Lehmann, Clara [3 ,4 ]
Gillor, Daniel [3 ]
Shimeliovich, Irma [1 ]
Unson-O'Brien, Cecilia [1 ]
Weiland, Daniela [2 ,3 ,4 ]
Robles, Alexander [9 ]
Kuemmerle, Tim [3 ]
Wyen, Christoph [3 ]
Levin, Rebeka [1 ]
Witmer-Pack, Maggi [1 ]
Eren, Kemal [10 ,11 ]
Ignacio, Caroline [7 ]
Kiss, Szilard [12 ]
West, Anthony P., Jr. [13 ]
Mouquet, Hugo [14 ]
Zingman, Barry S. [15 ,16 ]
Gulick, Roy M. [17 ]
Keler, Tibor [18 ]
Bjorkman, Pamela J. [13 ]
Seaman, Michael S. [9 ]
Hahn, Beatrice H. [5 ,6 ]
Faetkenheuer, Gerd [3 ,4 ]
Schlesinger, Sarah J. [1 ]
Nussenzweig, Michel C. [1 ,19 ]
Klein, Florian [2 ,3 ,4 ]
机构
[1] Rockefeller Univ, Lab Mol Immunol, 1230 York Ave, New York, NY 10021 USA
[2] Univ Cologne, Expt Immunol Lab, Ctr Mol Med Cologne, Cologne, Germany
[3] Univ Hosp Cologne, Dept Internal Med 1, Cologne, Germany
[4] German Ctr Infect Res, Partner Site Bonn Cologne, Cologne, Germany
[5] Univ Penn, Dept Med, Perelman Sch Med, Philadelphia, PA 19104 USA
[6] Univ Penn, Dept Microbiol, Perelman Sch Med, Philadelphia, PA 19104 USA
[7] Univ Calif San Diego, Dept Med, San Diego, CA 92103 USA
[8] Max Planck Inst Informat, Dept Computat Biol & Appl Algorithm, Saarbrucken, Germany
[9] Harvard Med Sch, Beth Israel Deaconess Med Ctr, Ctr Virol & Vaccine Res, Boston, MA USA
[10] Univ Calif San Diego, Dept Biomed Informat, San Diego, CA USA
[11] Univ Calif San Diego, Bioinformat & Syst Biol, San Diego, CA 92103 USA
[12] Cornell Univ, Weill Carnell Med Coll, Dept Ophthalmol, New York, NY 10021 USA
[13] CALTECH, Div Biol & Biol Engn, Pasadena, CA 91125 USA
[14] Inst Pasteur, Dept Immunol, Lab Humoral Response Pathogens, Paris, France
[15] Montefiore Med Ctr, Albert Einstein Coll Med, Div Infect Dis, Bronx, NY 10467 USA
[16] Einstein Rockefeller CUNY Ctr AIDS Res, Bronx, NY USA
[17] Weill Cornell Med, Div Infect Dis, New York, NY USA
[18] Celldex Therapeut, Hampton, VA USA
[19] Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10021 USA
基金
美国国家卫生研究院; 欧洲研究理事会;
关键词
BROADLY NEUTRALIZING ANTIBODIES; HUMAN MONOCLONAL-ANTIBODIES; HIV-1; VACCINE; GLYCAN RECOGNITION; PASSIVE TRANSFER; IN-VIVO; POTENT; VRC01; THERAPY; PHARMACOKINETICS;
D O I
10.1038/nm.4268
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Monoclonal antibody 10-1074 targets the V3 glycan supersite on the HIV-1 envelope (Env) protein. It is among the most potent anti-HIV-1 neutralizing antibodies isolated so far. Here we report on its safety and activity in 33 individuals who received a single intravenous infusion of the antibody. 10-1074 was well tolerated and had a half-life of 24.0 d in participants without HIV-1 infection and 12.8 d in individuals with HIV-1 infection. Thirteen individuals with viremia received the highest dose of 30 mg/kg 10-1074. Eleven of these participants were 10-1074-sensitive and showed a rapid decline in viremia by a mean of 1.52 logic copies/ml. Virologic analysis revealed the emergence of multiple independent 10-1074-resistant viruses in the first weeks after infusion. Emerging escape variants were generally resistant to the related V3-specific antibody PGT121, but remained sensitive to antibodies targeting nonoverlapping epitopes, such as the anti-CD4-binding-site antibodies 3BNC117 and VRC01. The results demonstrate the safety and activity of 10-1074 in humans and support the idea that antibodies targeting the V3 glycan supersite might be useful for the treatment and prevention of HIV-1 infection.
引用
收藏
页码:185 / 191
页数:7
相关论文
共 55 条
[1]   Nature, Position, and Frequency of Mutations Made in a Single Cycle of HIV-1 Replication [J].
Abram, Michael E. ;
Ferris, Andrea L. ;
Shao, Wei ;
Alvord, W. Gregory ;
Hughes, Stephen H. .
JOURNAL OF VIROLOGY, 2010, 84 (19) :9864-9878
[2]   Effect of HIV Antibody VRC01 on Viral Rebound after Treatment Interruption [J].
Bar, K. J. ;
Sneller, M. C. ;
Harrison, L. J. ;
Justement, J. S. ;
Overton, E. T. ;
Petrone, M. E. ;
Salantes, D. B. ;
Seamon, C. A. ;
Scheinfeld, B. ;
Kwan, R. W. ;
Learn, G. H. ;
Proschan, M. A. ;
Kreider, E. F. ;
Blazkova, J. ;
Bardsley, M. ;
Refsland, E. W. ;
Messer, M. ;
Clarridge, K. E. ;
Tustin, N. B. ;
Madden, P. J. ;
Oden, K. S. ;
O'Dell, S. J. ;
Jarocki, B. ;
Shiakolas, A. R. ;
Tressler, R. L. ;
Doria-Rose, N. A. ;
Bailer, R. T. ;
Ledgerwood, J. E. ;
Capparelli, E. V. ;
Lynch, R. M. ;
Graham, B. S. ;
Moir, S. ;
Koup, R. A. ;
Mascola, J. R. ;
Hoxie, J. A. ;
Fauci, A. S. ;
Tebas, P. ;
Chun, T-W .
NEW ENGLAND JOURNAL OF MEDICINE, 2016, 375 (21) :2037-2050
[3]   Therapeutic efficacy of potent neutralizing HIV-1-specific monoclonal antibodies in SHIV-infected rhesus monkeys [J].
Barouch, Dan H. ;
Whitney, James B. ;
Moldt, Brian ;
Klein, Florian ;
Oliveira, Thiago Y. ;
Liu, Jinyan ;
Stephenson, Kathryn E. ;
Chang, Hui-Wen ;
Shekhar, Karthik ;
Gupta, Sanjana ;
Nkolola, Joseph P. ;
Seaman, Michael S. ;
Smith, Kaitlin M. ;
Borducchi, Erica N. ;
Cabral, Crystal ;
Smith, Jeffrey Y. ;
Blackmore, Stephen ;
Sanisetty, Srisowmya ;
Perry, James R. ;
Beck, Matthew ;
Lewis, Mark G. ;
Rinaldi, William ;
Chakraborty, Arup K. ;
Poignard, Pascal ;
Nussenzweig, Michel C. ;
Burton, Dennis R. .
NATURE, 2013, 503 (7475) :224-+
[4]   Viral variants that initiate and drive maturation of V1V2-directed HIV-1 broadly neutralizing antibodies [J].
Bhiman, Jinal N. ;
Anthony, Colin ;
Doria-Rose, Nicole A. ;
Karimanzira, Owen ;
Schramm, Chaim A. ;
Khoza, Thandeka ;
Kitchin, Dale ;
Botha, Gordon ;
Gorman, Jason ;
Garrett, Nigel J. ;
Karim, Salim S. Abdool ;
Shapiro, Lawrence ;
Williamson, Carolyn ;
Kwong, Peter D. ;
Mascola, John R. ;
Morris, Lynn ;
Moore, Penny L. .
NATURE MEDICINE, 2015, 21 (11) :1332-1336
[5]   Broadly Neutralizing Anti-HIV-1 Antibodies Require Fc Effector Functions for In Vivo Activity [J].
Bournazos, Stylianos ;
Klein, Florian ;
Pietzsch, John ;
Seaman, Michael S. ;
Nussenzweig, Michel C. ;
Ravetch, Jeffrey V. .
CELL, 2014, 158 (06) :1243-1253
[6]   GENERATION OF HUMAN MONOCLONAL-ANTIBODIES AGAINST HIV-1 PROTEINS - ELECTROFUSION AND EPSTEIN-BARR-VIRUS TRANSFORMATION FOR PERIPHERAL-BLOOD LYMPHOCYTE IMMORTALIZATION [J].
BUCHACHER, A ;
PREDL, R ;
STRUTZENBERGER, K ;
STEINFELLNER, W ;
TRKOLA, A ;
PURTSCHER, M ;
GRUBER, G ;
TAUER, C ;
STEINDL, F ;
JUNGBAUER, A ;
KATINGER, H .
AIDS RESEARCH AND HUMAN RETROVIRUSES, 1994, 10 (04) :359-369
[7]   Antibody responses to envelope glycoproteins in HIV-1 infection [J].
Burton, Dennis R. ;
Mascola, John R. .
NATURE IMMUNOLOGY, 2015, 16 (06) :571-576
[8]   Viraemia suppressed in HIV-1-infected humans by broadly neutralizing antibody 3BNC117 [J].
Caskey, Marina ;
Klein, Florian ;
Lorenzi, Julio C. C. ;
Seaman, Michael S. ;
West, Anthony P., Jr. ;
Buckley, Noreen ;
Kremer, Gisela ;
Nogueira, Lilian ;
Braunschweig, Malte ;
Scheid, Johannes F. ;
Horwitz, Joshua A. ;
Shimeliovich, Irina ;
Ben-Avraham, Sivan ;
Witmer-Pack, Maggi ;
Platten, Martin ;
Lehmann, Clara ;
Burke, Leah A. ;
Hawthorne, Thomas ;
Gorelick, Robert J. ;
Walker, Bruce D. ;
Keler, Tibor ;
Gulick, Roy M. ;
Faetkenheuer, Gerd ;
Schlesinger, Sarah J. ;
Nussenzweig, Michel C. .
NATURE, 2015, 522 (7557) :487-+
[9]   HIV POPULATION-DYNAMICS IN-VIVO - IMPLICATIONS FOR GENETIC-VARIATION, PATHOGENESIS, AND THERAPY [J].
COFFIN, JM .
SCIENCE, 1995, 267 (5197) :483-489
[10]   Structural Evolution of Glycan Recognition by a Family of Potent HIV Antibodies [J].
Garces, Fernando ;
Sok, Devin ;
Kong, Leopold ;
McBride, Ryan ;
Kim, Helen J. ;
Saye-Francisco, Karen F. ;
Julien, Jean-Philippe ;
Hua, Yuanzi ;
Cupo, Albert ;
Moore, John P. ;
Paulson, James C. ;
Ward, Andrew B. ;
Burton, Dennis R. ;
Wilson, Ian A. .
CELL, 2014, 159 (01) :69-79